{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:05:02Z","timestamp":1770473102879,"version":"3.49.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,6,1]]},"abstract":"<jats:p>The lack of diagnostic certainty in some patients makes it difficult to distinguish between primary and secondary forms of thrombocytosis. To augment current diagnostic studies for thrombocytosis, we retrospectively evaluated clinical records and bone marrow trephine specimens of 183 patients with thrombocytosis\u2014164 with essential thrombocythemia (ET), 19 with reactive thrombocytosis (RT)\u2014for bone marrow angiogenesis, bone marrow megakaryocyte c-Mpl staining, and morphologic evidence of megakaryocyte proliferation. Angiogenesis was increased in patients with ET compared with healthy controls (P\u2009&amp;lt;\u2009.0001) and patients with RT (P\u2009=\u2009.006). In addition, an increase in angiogenesis was associated with certain disease features such as splenomegaly (P\u2009=\u2009.004) and reticulin fibrosis (P\u2009=\u2009.005). Decreased megakaryocyte c-Mpl staining was observed in a heterogeneous pattern in ET compared with healthy controls (P\u2009&amp;lt;\u2009.0001) and RT (P\u2009&amp;lt;\u2009.0001). Histologic stratifying criteria incorporating increased angiogenesis, decreased megakaryocyte c-Mpl expression, and marked megakaryocyte proliferation in the bone marrow was highly sensitive (97%) and specific (95%) for distinguishing ET from RT (P\u2009&amp;lt;\u2009.0001). However, with the current duration of follow-up available on the patients, none of the histologic features evaluated have yet demonstrated prognostic value for subsequent clinical course, vascular events, or survival.<\/jats:p>","DOI":"10.1182\/blood.v99.11.4131","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T21:48:18Z","timestamp":1033508898000},"page":"4131-4137","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia"],"prefix":"10.1182","volume":"99","author":[{"given":"Ruben A.","family":"Mesa","sequence":"first","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, the Division of Hematopathology, and the Cancer Center Statistics Unit, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, the Division of Hematopathology, and the Cancer Center Statistics Unit, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Yang","family":"Li","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, the Division of Hematopathology, and the Cancer Center Statistics Unit, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Young","family":"Yoon","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, the Division of Hematopathology, and the Cancer Center Statistics Unit, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, the Division of Hematopathology, and the Cancer Center Statistics Unit, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgene","family":"Schroeder","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, the Division of Hematopathology, and the Cancer Center Statistics Unit, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, the Division of Hematopathology, and the Cancer Center Statistics Unit, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021218470011800_B1","first-page":"177","article-title":"Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.","volume":"23","author":"Murphy","year":"1986","journal-title":"Semin Hematol."},{"key":"2020021218470011800_B2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1600-0609.1988.tb00188.x","article-title":"Use of splenic volume estimation to distinguish primary thrombocythaemia from reactive thrombocytosis.","volume":"40","author":"Messinezy","year":"1988","journal-title":"Eur J Haematol."},{"key":"2020021218470011800_B3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9343(94)90306-9","article-title":"Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis.","volume":"97","author":"Tefferi","year":"1994","journal-title":"Am J Med."},{"key":"2020021218470011800_B4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.1993.tb08271.x","article-title":"Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications.","volume":"83","author":"Juvonen","year":"1993","journal-title":"Br J Haematol."},{"key":"2020021218470011800_B5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0609.1989.tb00329.x","article-title":"Circulating erythroid and megakaryocytic progenitors in polycythaemia vera and essential thrombocythaemia.","volume":"43","author":"Florensa","year":"1989","journal-title":"Eur J Haematol."},{"key":"2020021218470011800_B6","first-page":"271","article-title":"Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia.","volume":"9","author":"Florensa","year":"1995","journal-title":"Leukemia."},{"key":"2020021218470011800_B7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF03401559","article-title":"Angiogenesis inhibitors generated by tumors.","volume":"1","author":"Folkman","year":"1995","journal-title":"Mol Med."},{"key":"2020021218470011800_B8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","article-title":"Bone marrow angiogenesis and progression in multiple myeloma.","volume":"87","author":"Vacca","year":"1994","journal-title":"Br J Haematol."},{"key":"2020021218470011800_B9","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.leu.2401825","article-title":"Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia.","volume":"14","author":"Kini","year":"2000","journal-title":"Leukemia."},{"key":"2020021218470011800_B10","first-page":"815","article-title":"Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.","volume":"150","author":"Perez-Atayde","year":"1997","journal-title":"Am J Pathol."},{"key":"2020021218470011800_B11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V95.1.309","article-title":"Evidence of increased angiogenesis in patients with acute myeloid leukemia.","volume":"95","author":"Hussong","year":"2000","journal-title":"Blood."},{"key":"2020021218470011800_B12","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood."},{"key":"2020021218470011800_B13","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood.V96.10.3374","article-title":"Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia.","volume":"96","author":"Mesa","year":"2000","journal-title":"Blood."},{"key":"2020021218470011800_B14","first-page":"3111","article-title":"Prognostic value of bone marrow angiogenesis in multiple myeloma.","volume":"6","author":"Rajkumar","year":"2000","journal-title":"Clin Cancer Res."},{"key":"2020021218470011800_B15","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma.","volume":"341","author":"Singhal","year":"1999","journal-title":"N Engl J Med."},{"key":"2020021218470011800_B16","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1182\/blood.V96.12.4007","article-title":"Serious myeloproliferative reactions associated with the use of thalidomide in myelofibrosis with myeloid metaplasia [abstract].","volume":"96","author":"Tefferi","year":"2000","journal-title":"Blood."},{"key":"2020021218470011800_B17","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/blood.V90.10.4031","article-title":"Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.","volume":"90","author":"Horikawa","year":"1997","journal-title":"Blood."},{"key":"2020021218470011800_B18","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V94.8.2555.420k14_2555_2561","article-title":"Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera.","volume":"94","author":"Moliterno","year":"1999","journal-title":"Blood."},{"key":"2020021218470011800_B19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1034\/j.1600-0609.2000.90235.x","article-title":"Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates.","volume":"65","author":"Yoon","year":"2000","journal-title":"Eur J Haematol."},{"key":"2020021218470011800_B20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.V96.2.771","article-title":"Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis.","volume":"96","author":"Tefferi","year":"2000","journal-title":"Blood."},{"key":"2020021218470011800_B21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"2020021218470011800_B22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc [B]."},{"key":"2020021218470011800_B23","first-page":"29","article-title":"Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment.","volume":"34","author":"Murphy","year":"1997","journal-title":"Semin Hematol."},{"key":"2020021218470011800_B24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V93.2.417","article-title":"A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications.","volume":"93","author":"Harrison","year":"1999","journal-title":"Blood."},{"key":"2020021218470011800_B25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000207547","article-title":"Endogenous erythroid colony formation by peripheral blood mononuclear cells from patients with myelofibrosis and polycythemia vera.","volume":"62","author":"Lutton","year":"1979","journal-title":"Acta Haematol."},{"key":"2020021218470011800_B26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0609.1982.tb00602.x","article-title":"Circulating haematopoietic progenitors in myelofibrosis.","volume":"29","author":"Partanen","year":"1982","journal-title":"Scand J Haematol."},{"key":"2020021218470011800_B27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0609.1989.tb01219.x","article-title":"Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders.","volume":"42","author":"Battegay","year":"1989","journal-title":"Eur J Haematol."},{"key":"2020021218470011800_B28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2141.1995.tb05153.x","article-title":"The determination of spontaneous megakaryocyte colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis.","volume":"90","author":"Rolovic","year":"1995","journal-title":"Br J Haematol."},{"key":"2020021218470011800_B29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V86.2.419.bloodjournal862419","article-title":"Thrombopoietin: the primary regulator of platelet production.","volume":"86","author":"Kaushansky","year":"1995","journal-title":"Blood."},{"key":"2020021218470011800_B30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0002-9343(98)00090-4","article-title":"Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis.","volume":"104","author":"Wang","year":"1998","journal-title":"Am J Med."},{"key":"2020021218470011800_B31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-2141.1997.4633267.x","article-title":"Thrombopoietin measurement in thrombocytosis: dysregulation and lack of feedback inhibition in essential thrombocythaemia.","volume":"99","author":"Pitcher","year":"1997","journal-title":"Br J Haematol."},{"key":"2020021218470011800_B32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood.V92.4.1091","article-title":"Familial essential thrombocythemia associated with one-base deletion in the 5'-untranslated region of the thrombopoietin gene.","volume":"92","author":"Kondo","year":"1998","journal-title":"Blood."},{"key":"2020021218470011800_B33","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1365-2141.1998.00921.x","article-title":"The activating splice mutation in intron 3 of the thrombopoietin gene is not found in patients with non-familial essential thrombocythaemia.","volume":"102","author":"Harrison","year":"1998","journal-title":"Br J Haematol."},{"key":"2020021218470011800_B34","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/sj.leu.2400845","article-title":"Study of the thrombopoietin receptor in essential thrombocythemia.","volume":"11","author":"Kiladjian","year":"1997","journal-title":"Leukemia."},{"key":"2020021218470011800_B35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM199802263380903","article-title":"Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.","volume":"338","author":"Moliterno","year":"1998","journal-title":"N Engl J Med."},{"key":"2020021218470011800_B36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/blood.V93.1.125","article-title":"Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.","volume":"93","author":"Taksin","year":"1999","journal-title":"Blood."},{"key":"2020021218470011800_B37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-8652(200003)63:3<131::AID-AJH4>3.0.CO;2-#","article-title":"Strong inverse correlation between serum TPO level and platelet count in essential thrombocythemia.","volume":"63","author":"Tomita","year":"2000","journal-title":"Am J Hematol."},{"key":"2020021218470011800_B38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2257.1999.00226.x","article-title":"Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant.","volume":"21","author":"Cerutti","year":"1999","journal-title":"Clin Lab Haematol."},{"key":"2020021218470011800_B39","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0022-2143(99)90154-3","article-title":"Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis.","volume":"134","author":"Hsu","year":"1999","journal-title":"J Lab Clin Med."},{"key":"2020021218470011800_B40","first-page":"475","article-title":"Bone marrow and peripheral blood findings in patients with extreme thrombocytosis: a report of 63 cases.","volume":"115","author":"Buss","year":"1991","journal-title":"Arch Pathol Lab Med."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/11\/4131\/1685825\/h81102004131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/11\/4131\/1685825\/h81102004131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T06:15:47Z","timestamp":1733811347000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/11\/4131\/106909\/Diagnostic-and-prognostic-value-of-bone-marrow"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,1]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,6,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.11.4131","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6,1]]}}}